| __timestamp | Arrowhead Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 305409000 |
| Thursday, January 1, 2015 | 34718089 | 377080000 |
| Friday, January 1, 2016 | 40998209 | 432829000 |
| Sunday, January 1, 2017 | 32022880 | 496079000 |
| Monday, January 1, 2018 | 19110051 | 557616000 |
| Tuesday, January 1, 2019 | 26556257 | 658498000 |
| Wednesday, January 1, 2020 | 52275890 | 770456000 |
| Friday, January 1, 2021 | 80981000 | 840100000 |
| Saturday, January 1, 2022 | 124431000 | 944700000 |
| Sunday, January 1, 2023 | 90932000 | 1136600000 |
| Monday, January 1, 2024 | 98761000 | 1464300000 |
Data in motion
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to SG&A cost management.
From 2014 to 2023, Vertex Pharmaceuticals consistently reported higher SG&A expenses, peaking at over $1.1 billion in 2023. This represents a staggering 272% increase from 2014. In contrast, Arrowhead Pharmaceuticals, while also experiencing growth, maintained a more conservative increase of approximately 304% over the same period, reaching around $98 million in 2024.
Vertex's higher SG&A costs may reflect aggressive expansion and investment in marketing and administrative capabilities. Meanwhile, Arrowhead's more modest spending could indicate a focus on lean operations. Understanding these strategies provides valuable insights into each company's market positioning and operational priorities.
Eli Lilly and Company and Vertex Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited Trends and Insights
Vertex Pharmaceuticals Incorporated or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
Catalent, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Verona Pharma plc and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.